Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02154490
Brief Title: Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

First Submitted : May 30, 2014
First Submitted that Met QC Criteria : June 2, 2014
First Posted : June 3, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 9, 2020
Last Update Posted : November 12, 2020